Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Gains from Sales and Divestitures (2019 - 2022)

Harte Hanks has reported Gains from Sales and Divestitures over the past 9 years, most recently at $69110.0 for Q4 2022.

  • Quarterly Gains from Sales and Divestitures rose 1566.91% to $69110.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $69110.0 through Dec 2022, up 1566.91% year-over-year, with the annual reading at $69110.0 for FY2022, 1566.91% up from the prior year.
  • Gains from Sales and Divestitures was $69110.0 for Q4 2022 at Harte Hanks, up from $4146.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $69110.0 in Q4 2022 and troughed at $4146.0 in Q4 2021.
  • The 4-year median for Gains from Sales and Divestitures is $9740.5 (2019), against an average of $23184.2.
  • Year-over-year, Gains from Sales and Divestitures tumbled 48.38% in 2021 and then soared 1566.91% in 2022.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $11449.0 in 2019, then dropped by 29.85% to $8032.0 in 2020, then crashed by 48.38% to $4146.0 in 2021, then soared by 1566.91% to $69110.0 in 2022.
  • Per Business Quant, the three most recent readings for HHS's Gains from Sales and Divestitures are $69110.0 (Q4 2022), $4146.0 (Q4 2021), and $8032.0 (Q4 2020).